A detailed history of Centerpoint Advisors, LLC transactions in Lemaitre Vascular Inc stock. As of the latest transaction made, Centerpoint Advisors, LLC holds 17,755 shares of LMAT stock, worth $1.56 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares
17,755
Previous 17,793 0.21%
Holding current value
$1.56 Million
Previous $1.18 Million 23.71%
% of portfolio
0.53%
Previous 0.44%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

SELL
$62.62 - $83.59 $2,379 - $3,176
-38 Reduced 0.21%
17,755 $1.46 Million
Q3 2023

Nov 01, 2023

SELL
$53.45 - $67.01 $213 - $268
-4 Reduced 0.02%
17,793 $969,000
Q1 2023

May 03, 2023

BUY
$44.73 - $51.68 $782,059 - $903,573
17,484 Added 5585.94%
17,797 $916,000
Q4 2022

Jan 24, 2023

BUY
$41.94 - $52.25 $13,127 - $16,354
313 New
313 $14,000

Others Institutions Holding LMAT

About LEMAITRE VASCULAR INC


  • Ticker LMAT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 21,962,900
  • Market Cap $1.93B
  • Description
  • LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that tem...
More about LMAT
Track This Portfolio

Track Centerpoint Advisors, LLC Portfolio

Follow Centerpoint Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Centerpoint Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Centerpoint Advisors, LLC with notifications on news.